Open an Account
search icon
1
NOTIFICATIONS
Best Algo trading app in India
Bigul

Fermenta Biotech Ltd - 506414 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Pursuant to the relevant provisions of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the officials of the Company will be interacting with a group of Investors and Analysts over audio-video conference on Friday, December 11, 2020. This is to further inform that the 'Earnings Presentation for Quarter 2 of Financial year 2020-21' to be shared with the Investors in the above interaction, has been uploaded on the website of the Company - www.fermentabiotech.com and is also available on BSE Limited website - www.bseindia.com. No unpublished price sensitive information (UPSI) is intended to be discussed during the interactions. This information is submitted to you pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015. Kindly note that changes may happen due to exigencies on the part of Host / Company
10-12-2020
Bigul

Fermenta Biotech Ltd - 506414 - Disclosure Of Related Party Transactions For The Half-Year Ended September 30, 2020

 Pursuant to Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the disclosure of Related Party Transactions for the half year ended September 30, 2020, on a consolidated basis, in the format as specified in the relevant accounting standards.
07-12-2020
Bigul

Fermenta Biotech Ltd - 506414 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

 Pursuant to the relevant provisions of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015 ('Listing Regulations') and further to our intimation to BSE Limited dated December 03, 2020 under Regulation 30 of Listing Regulations regarding acquisition of 52% membership interest by Fermenta Biotech Limited's wholly owned subsidiary Fermenta Biotech USA, LLC in AGD Nutrition, LLC, we hereby enclose the Joint Press Release by Fermenta Biotech Limited and AGD Nutrition, LLC regarding the above acquisition. This information will thereafter be uploaded on the website of the Company at www.fermentabiotech.com Kindly take the above on record.
03-12-2020
Bigul

Fermenta Biotech Ltd - 506414 - Announcement under Regulation 30 (LODR)-Acquisition

 Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations') Pursuant to the provisions of Regulation 30 of Listing Regulations, we write to inform you that Fermenta Biotech USA, LLC, a wholly owned subsidiary of the Company, has acquired a membership interest in AGD Nutrition, LLC. The required disclosure as per SEBI circular CIR/CFD/CMD/4/2015 dated September 09, 2015 read with Regulation 30 of Listing Regulations is annexed as Annexure 1.
03-12-2020
Bigul

Fermenta Biotech Ltd - 506414 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Pursuant to the relevant provisions of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the officials of the Company will be interacting with a group of Investors and Analysts over audio-video conference on Tuesday, December 01, 2020. This is to further inform that the 'Earnings Presentation for Quarter 2 of Financial year 2020-21' to be shared with the Investors in the above interaction, has been uploaded on the website of the Company - www.fermentabiotech.com and is also available on BSE Limited website - www.bseindia.com. No unpublished price sensitive information (UPSI) is intended to be discussed during the interactions. This information is submitted to you pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015.
01-12-2020
Bigul

Fermenta Biotech Ltd - 506414 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

 Transcript of Schedule of Analysts / Institutional Investors meeting held on November 11, 2020 to discuss the financial performance of the Company for the quarter ended September 30, 2020 We hereby enclose the Transcript of conference call with Analysts / Institutional Investors held on Wednesday, November 11, 2020 at 11:00 a.m. to discuss the financial performance of the Company for the quarter ended September 30, 2020. The above Transcript shall also be uploaded on Company's website at www.fermentabiotech.com This information is submitted to you pursuant to the provisions of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015.
23-11-2020
Bigul

Fermenta Biotech Ltd - 506414 - Announcement under Regulation 30 (LODR)-Investor Presentation

 Intimation of Investor Relations Presentation - November 2020 Pursuant to the relevant provisions of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we hereby enclose a copy of Investor Relations Presentation for November 2020 for your information. The said Investor Presentation will thereafter be uploaded on Company's website at www.fermentabiotech.com This information is submitted to you pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015. Kindly take the same on records.
23-11-2020
Bigul

Fermenta Biotech Ltd - 506414 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Intimation of Schedule of Analysts / Institutional Investors meeting under the SEBI LODR, Regulations 2015 Pursuant to the relevant provisions of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the officials of the Company will be interacting with a group of Investors and Analysts over audio-video conference on Friday, November 20, 2020. This is to further inform that the 'Earnings Presentation for Quarter 2 of Financial year 2020-21' to be shared with the Investors in the above interaction, has been uploaded on the website of the Company - www.fermentabiotech.com and is also available on BSE Limited website - www.bseindia.com. No unpublished price sensitive information (UPSI) is intended to be discussed during the interactions. This information is submitted to you pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015.
20-11-2020
Bigul

Fermenta Biotech Ltd - 506414 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Intimation of Schedule of Analysts / Institutional Investors meetings under the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015 Pursuant to the relevant provisions of SEBI LODR, Regulations 2015, we would like to inform you that the officials of the Company will be interacting with a group of Investors and Analysts over audio-video conference(s) on Thursday, November 12, 2020. This is to further inform that the 'Earnings Presentation for Quarter 2 of Financial year 2020-21' to be shared with the Investors in the above interaction, has been uploaded on the website of the Company - www.fermentabiotech.com and is also available on BSE Limited website - www.bseindia.com. No unpublished price sensitive information (UPSI) is intended to be discussed during the interactions. This information is submitted to you pursuant to Regulation 30 of the Securities and Exchange Board of India LODR, Regulations, 2015.
12-11-2020

Earnings Call for Q2FY21 of Fermenta Biotech

 Conference Call with Fermenta Biotech Ltd. Management and Analysts on Q2FY21 Performance and Outlook. Listen to the full earnings transcript.
12-11-2020
Next Page
Close

Let's Open Free Demat Account